Losartan-containing drugs recall in Canada: potential cancer risk
In plain language
This recall involves multiple Losartan-containing drugs sold in Canada by Teva Canada, Apotex Inc., Pharmascience Inc., and Pro Doc Limitée. They are being recalled due to the potential presence of a nitrosamine impurity, NMBA, which could increase the risk of cancer with long-term exposure. Patients should not stop taking their medication unless advised by their healthcare provider and should consult them with any concerns.
What to do
- Do not stop taking your medication unless advised by your healthcare provider.
- Consult your healthcare professional if you have questions or concerns about your medication.
- Contact the respective manufacturers for more information if needed.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Potential cancer risk from nitrosamine impurity
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Potential cancer risk from nitrosamine impurity
What should consumers do?
Do not stop taking your medication unless advised by your healthcare provider. Consult your healthcare professional if you have questions or concerns about your medication. Contact the respective manufacturers for more information if needed.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Potential cancer risk from nitrosamine impurity
When was this product recalled?
This product was recalled on March 9, 2019.